ConductScience.org, home

Paper2168149

Proportion of DNA gyrase mutants among quinolone-resistant strains of Pseudomonas aeruginosa.

Yoshida H and 3 others. Antimicrob Agents Chemother, 1990. Cited by 71 papers, by iCite.

Cite this record

ConductScience Library. Proportion of DNA gyrase mutants among quinolone-resistant strains of Pseudomonas aeruginosa. Papers, record 2168149. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2168149

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Proportion of DNA gyrase mutants among quinolone-resistant strains of Pseudomonas aeruginosa.
PubMed
Journal
Antimicrob Agents Chemother
PubMed
Year
1990
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
71
iCite
Relative citation ratio, by iCite
2.67
iCite
Revised in PubMed
2021-05-26
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Yoshida HH
2Nakamura MM
3Bogaki MM
4Nakamura SS

Source PubMed

Download CSV of authors

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Anti-Infective AgentsMajor topic
DNA Topoisomerases, Type IIMajor topic
Pseudomonas aeruginosaMajor topic
4-Quinolones
Drug Resistance, Microbial
Mutation
Transformation, Genetic

Source PubMed

Download CSV of topics

References17

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
14208771Studies on the mechanism of action of nalidixic acid.Antimicrob Agents Chemother1973https://conductscience.org/library/papers/4208771PubMed
24895844Escherichia coli K-12 mutants resistant to nalidixic acid: genetic mapping and dominance studies.J Bacteriol1969https://conductscience.org/library/papers/4895844PubMed
3347446Purification of subunits of Escherichia coli DNA gyrase and reconstitution of enzymatic activity.Proc Natl Acad Sci U S A1978https://conductscience.org/library/papers/347446PubMed
46821455Resistance of Pseudomonas aeruginosa PAO to nalidixic acid and low levels of beta-lactam antibiotics: mapping of chromosomal genes.Antimicrob Agents Chemother1982https://conductscience.org/library/papers/6821455PubMed
53020376Nalidixic acid-resistant mutations of the gyrB gene of Escherichia coli.Mol Gen Genet1986https://conductscience.org/library/papers/3020376PubMed
63532944Isolation and characterization of norfloxacin-resistant mutants of Escherichia coli K-12.Antimicrob Agents Chemother1986https://conductscience.org/library/papers/3532944PubMed
73026239Purification and properties of DNA gyrase from a fluoroquinolone-resistant strain of Escherichia coli.Antimicrob Agents Chemother1986https://conductscience.org/library/papers/3026239PubMed
83032915Some properties of subunits of DNA gyrase from Pseudomonas aeruginosa PAO1 and its nalidixic acid-resistant mutant.J Bacteriol1987https://conductscience.org/library/papers/3032915PubMed
93034057Mechanisms of action of and resistance to ciprofloxacin.Am J Med1987https://conductscience.org/library/papers/3034057PubMed
103111356Mutations producing resistance to norfloxacin in Pseudomonas aeruginosa.Antimicrob Agents Chemother1987https://conductscience.org/library/papers/3111356PubMed
112830458Quinolone-resistant mutations of the gyrA gene of Escherichia coli.Mol Gen Genet1988https://conductscience.org/library/papers/2830458PubMed
122837141Genetic and physiological characterization of ciprofloxacin resistance in Pseudomonas aeruginosa PAO.Antimicrob Agents Chemother1988https://conductscience.org/library/papers/2837141PubMed
133148293Low- and intermediate-copy-number cloning vectors based on the Pseudomonas plasmid pVS1.Antonie Van Leeuwenhoek1988https://conductscience.org/library/papers/3148293PubMed
142655532gyrA and gyrB mutations in quinolone-resistant strains of Escherichia coli.Antimicrob Agents Chemother1989https://conductscience.org/library/papers/2655532PubMed
152502066Characterization of mechanisms of quinolone resistance in Pseudomonas aeruginosa strains isolated in vitro and in vivo during experimental endocarditis.Antimicrob Agents Chemother1989https://conductscience.org/library/papers/2502066PubMed
163010850Genetic and biochemical characterization of norfloxacin resistance in Escherichia coli.Antimicrob Agents Chemother1986https://conductscience.org/library/papers/3010850PubMed
17337300Nalidixic acid resistance: a second genetic character involved in DNA gyrase activity.Proc Natl Acad Sci U S A1977https://conductscience.org/library/papers/337300PubMed

Download CSV of references

Cited by42

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 71 citations.

PMIDTitleJournalYearIn PapersSource
41609711Accelerated evolution in networked metapopulations of Pseudomonas aeruginosa.Elife2026https://conductscience.org/library/papers/41609711PubMed
36611992Pseudomonas aeruginosa: Infections, Animal Modeling, and Therapeutics.Cells2023https://conductscience.org/library/papers/36611992PubMed
28744479Evolution of Cost-Free Resistance under Fluctuating Drug Selection in Pseudomonas aeruginosa.mSphere2017https://conductscience.org/library/papers/28744479PubMed
27572404Molecular Epidemiology of Mutations in Antimicrobial Resistance Loci of Pseudomonas aeruginosa Isolates from Airways of Cystic Fibrosis Patients.Antimicrob Agents Chemother2016https://conductscience.org/library/papers/27572404PubMed
25367914The resistome of Pseudomonas aeruginosa in relationship to phenotypic susceptibility.Antimicrob Agents Chemother2015https://conductscience.org/library/papers/25367914PubMed
24532839A temporal examination of the planktonic and biofilm proteome of whole cell Pseudomonas aeruginosa PAO1 using quantitative mass spectrometry.Mol Cell Proteomics2014https://conductscience.org/library/papers/24532839PubMed
23284623Tracking down antibiotic-resistant Pseudomonas aeruginosa isolates in a wastewater network.PLoS One2012https://conductscience.org/library/papers/23284623PubMed
23274661Quantitative contributions of target alteration and decreased drug accumulation to Pseudomonas aeruginosa fluoroquinolone resistance.Antimicrob Agents Chemother2013https://conductscience.org/library/papers/23274661PubMed
23028345Genomics of adaptation during experimental evolution of the opportunistic pathogen Pseudomonas aeruginosa.PLoS Genet2012https://conductscience.org/library/papers/23028345PubMed
11850246Topoisomerase II and IV quinolone resistance-determining regions in Stenotrophomonas maltophilia clinical isolates with different levels of quinolone susceptibility.Antimicrob Agents Chemother2002https://conductscience.org/library/papers/11850246PubMed
11796341Type II topoisomerase quinolone resistance-determining regions of Aeromonas caviae, A. hydrophila, and A. sobria complexes and mutations associated with quinolone resistance.Antimicrob Agents Chemother2002https://conductscience.org/library/papers/11796341PubMed
10952561Efflux-mediated resistance to fluoroquinolones in gram-negative bacteria.Antimicrob Agents Chemother2000https://conductscience.org/library/papers/10952561PubMed
10681343Molecular mechanisms of fluoroquinolone resistance in Pseudomonas aeruginosa isolates from cystic fibrosis patients.Antimicrob Agents Chemother2000https://conductscience.org/library/papers/10681343PubMed
10103206Alterations in GyrA and ParC associated with fluoroquinolone resistance in Enterococcus faecium.Antimicrob Agents Chemother1999https://conductscience.org/library/papers/10103206PubMed
10049263Cloning, expression, and enzymatic characterization of Pseudomonas aeruginosa topoisomerase IV.Antimicrob Agents Chemother1999https://conductscience.org/library/papers/10049263PubMed
9925546Detection of gyrA mutations among 335 Pseudomonas aeruginosa strains isolated in Japan and their susceptibilities to fluoroquinolones.Antimicrob Agents Chemother1999https://conductscience.org/library/papers/9925546PubMed
9869566Type II topoisomerase mutations in ciprofloxacin-resistant strains of Pseudomonas aeruginosa.Antimicrob Agents Chemother1999https://conductscience.org/library/papers/9869566PubMed
9087505Conservation of the multidrug resistance efflux gene oprM in Pseudomonas aeruginosa.Antimicrob Agents Chemother1997https://conductscience.org/library/papers/9087505PubMed
8843298
Quinolone resistance mutations in topoisomerase IV: relationship to the flqA locus and genetic evidence that topoisomerase IV is the primary target and DNA gyrase is the secondary target of fluoroquinolones in Staphylococcus aureus.
Antimicrob Agents Chemother1996https://conductscience.org/library/papers/8843298PubMed
8726027Resistance to fluoroquinolones in Escherichia coli isolated from poultry.Antimicrob Agents Chemother1996https://conductscience.org/library/papers/8726027PubMed

See all 42 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/2168149

GET https://conductscience.org/api/papers/v1/2168149/cited_by?page=2